NeuroStar Advanced Therapy for Mental Health Recognized as Top Neuromodulation Solution Provider in 2021
January 10, 2022 08:31 ET
|
Neuronetics
MALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces 510(k) Clearance of MT Cap Technology for NeuroStar® Advanced Therapy for Mental Health
December 20, 2021 08:31 ET
|
Neuronetics
MALVERN, Pa., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Key Role for NeuroStar Advanced Therapy at 4th International Brain Stimulation Conference
December 06, 2021 08:31 ET
|
Neuronetics
MALVERN, Pa., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics and River Region Psychiatry Announce Exclusive Partnership
November 08, 2021 10:00 ET
|
Neuronetics
Partnership Will Bring Non-drug NeuroStar® Advanced Therapy For Mental Health To Thousands of Patients Across the Southeast MALVERN, Pa., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc....
Neuronetics Celebrates 235,000 Treatment Milestone for Success TMS
October 26, 2021 08:30 ET
|
Neuronetics
MALVERN, Pa., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health
October 19, 2021 08:31 ET
|
Neuronetics
System Innovations Improve Efficiencies for Healthcare Practices and Patients MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology...
NeuroStar® Advanced Therapy Recognizes National Depression Education and Awareness Month With New Campaign Launch
October 04, 2021 08:40 ET
|
Neuronetics
MALVERN, Pa., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve...
UPDATE - New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over H-Coil TMS
September 22, 2021 18:33 ET
|
Neuronetics
MALVERN, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve...
New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over H-Coil TMS
September 21, 2021 08:30 ET
|
Neuronetics
MALVERN, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics and Zion Healing Announce First Franchise Model for TMS Clinics
September 07, 2021 08:30 ET
|
Neuronetics
MALVERN, Pa. and ST. GEORGE, Utah, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing...